Literature DB >> 16223550

Genetic variation in the choline acetyltransferase (CHAT) gene may be associated with the risk of Alzheimer's disease.

Ayla Ozturk1, Steven T DeKosky, M Ilyas Kamboh.   

Abstract

Several independent linkage studies have mapped a broad susceptibility region for Alzheimer's disease (AD) on the long arm of chromosome 10. There are several biological candidate genes in this region, including choline acetyltransferase (CHAT). A number of studies have examined the role of CHAT genetic variants with AD risk and age-at-onset (AAO), but the results are equivocal. We examined the association of three Single Nucleotide Polymorphisms (SNPs) in the CHAT gene in 1001 white sporadic late-onset AD (LOAD) cases and 708 white controls. We also examined the role of these three SNP with quantitative traits of AD including AAO, disease duration, and Mini-Mental State Examination (MMSE) score. We observed both allelic and genotypic associations of the intron 9 SNP with AD risk in the total sample (p = 0.029 for genotype and p = 0.028 for allele frequency differences) as well as among non-APOE*4 carriers (p = 0.007 for genotype and p = 0.006 for allele frequency differences). Three-site haplotype analysis confirmed that haplotypes determined by the intron 9 SNP were associated with either risk (p = 0.0009) or protective (p = 0.0082) effects among non-APOE*4 carriers. The three CHAT SNPs also showed a modest association with MMSE score. Our data suggest that genetic variation in the CHAT gene may be associated with AD risk and quantitative traits related to AD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16223550      PMCID: PMC1609962          DOI: 10.1016/j.neurobiolaging.2005.08.024

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  18 in total

Review 1.  Molecular genetics of late-onset Alzheimer's disease.

Authors:  M Ilyas Kamboh
Journal:  Ann Hum Genet       Date:  2004-07       Impact factor: 1.670

Review 2.  Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system.

Authors:  Y Oda
Journal:  Pathol Int       Date:  1999-11       Impact factor: 2.534

3.  Identification of a single nucleotide polymorphism in the choline acetyltransferase gene associated with Alzheimer's disease.

Authors:  Victor Mubumbila; Anne Sutter; Ursula Ptok; Reinhard Heun; Christiane Quirin-Stricker
Journal:  Neurosci Lett       Date:  2002-11-15       Impact factor: 3.046

4.  Full genome screen for Alzheimer disease: stage II analysis.

Authors:  Amanda Myers; Fabienne Wavrant De-Vrieze; Peter Holmans; Marian Hamshere; Richard Crook; Danielle Compton; Helen Marshall; David Meyer; Shantia Shears; Jeremy Booth; Dzanan Ramic; Heather Knowles; John C Morris; Nigel Williams; Nadine Norton; Richard Abraham; Pat Kehoe; Hywel Williams; Varuni Rudrasingham; Francis Rice; Peter Giles; Nigel Tunstall; Lesley Jones; Simon Lovestone; Julie Williams; Michael J Owen; John Hardy; Alison Goate
Journal:  Am J Med Genet       Date:  2002-03-08

5.  Genetic variation in alpha(1)-antichymotrypsin and its association with Alzheimer's disease.

Authors:  Xiaoyan Wang; Steven T DeKosky; Erin Luedecking-Zimmer; Mary Ganguli; M Ilyas Kamboh
Journal:  Hum Genet       Date:  2002-03-19       Impact factor: 4.132

6.  Age at onset in two common neurodegenerative diseases is genetically controlled.

Authors:  Yi-Ju Li; William K Scott; Dale J Hedges; Fengyu Zhang; P Craig Gaskell; Martha A Nance; Ray L Watts; Jean P Hubble; William C Koller; Rajesh Pahwa; Matthew B Stern; Bradley C Hiner; Joseph Jankovic; Fred A Allen; Christopher G Goetz; Frank Mastaglia; Jeffrey M Stajich; Rachel A Gibson; Lefkos T Middleton; Ann M Saunders; Burton L Scott; Gary W Small; Kristin K Nicodemus; Allison D Reed; Donald E Schmechel; Kathleen A Welsh-Bohmer; P Michael Conneally; Allen D Roses; John R Gilbert; Jeffery M Vance; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Am J Hum Genet       Date:  2002-03-01       Impact factor: 11.025

Review 7.  The cholinergic hypothesis of geriatric memory dysfunction.

Authors:  R T Bartus; R L Dean; B Beer; A S Lippa
Journal:  Science       Date:  1982-07-30       Impact factor: 47.728

8.  Choline acetyltransferase G +4 A polymorphism confers a risk for Alzheimer's disease in concert with Apolipoprotein E epsilon4.

Authors:  Ki-Woong Kim; Young-Ju Suh; Woong-Yang Park; Jin-Hyeong Jhoo; Dong-Young Lee; Jong-Chul Youn; Kwang-Hyuck Lee; Jeong-Sun Seo; Jong-Inn Woo
Journal:  Neurosci Lett       Date:  2004-08-12       Impact factor: 3.046

9.  Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study.

Authors:  A J Slooter; M Cruts; S Kalmijn; A Hofman; M M Breteler; C Van Broeckhoven; C M van Duijn
Journal:  Arch Neurol       Date:  1998-07

10.  Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know.

Authors:  S Seshadri; D A Drachman; C F Lippa
Journal:  Arch Neurol       Date:  1995-11
View more
  14 in total

1.  Lack of association of two chromosome 10q24 SNPs with Alzheimer's disease.

Authors:  Ryan L Minster; Steven T DeKosky; M Ilyas Kamboh
Journal:  Neurosci Lett       Date:  2006-09-26       Impact factor: 3.046

2.  Statistical analysis of spatial expression patterns for spatially resolved transcriptomic studies.

Authors:  Shiquan Sun; Jiaqiang Zhu; Xiang Zhou
Journal:  Nat Methods       Date:  2020-01-27       Impact factor: 28.547

3.  Genetic variants in the choline acetyltransferase (ChAT) gene are modestly associated with normal cognitive function in the elderly.

Authors:  J Mengel-From; K Christensen; M Thinggaard; M McGue; L Christiansen
Journal:  Genes Brain Behav       Date:  2011-09-21       Impact factor: 3.449

Review 4.  Acute lung injury and the coagulation pathway: Potential role of gene polymorphisms in the protein C and fibrinolytic pathways.

Authors:  Anil Sapru; Joseph L Wiemels; John S Witte; Lorraine B Ware; Michael A Matthay
Journal:  Intensive Care Med       Date:  2006-06-13       Impact factor: 17.440

5.  Donepezil improves the cognitive impairment in a tree shrew model of Alzheimer's disease induced by amyloid-β1-40 via activating the BDNF/TrkB signal pathway.

Authors:  Hong Zheng; Shiwei Niu; Hongbin Zhao; Shude Li; Jianlin Jiao
Journal:  Metab Brain Dis       Date:  2018-08-13       Impact factor: 3.584

Review 6.  Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence.

Authors:  Tammy T Hshieh; Tamara G Fong; Edward R Marcantonio; Sharon K Inouye
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-07       Impact factor: 6.053

Review 7.  Cholinergic Modulation of the Immune System in Neuroinflammatory Diseases.

Authors:  Marcella Reale; Erica Costantini
Journal:  Diseases       Date:  2021-04-12

Review 8.  Genetic Association of CHAT rs3810950 and rs2177369 Polymorphisms with the Risk of Alzheimer's Disease: A Meta-Analysis.

Authors:  Yong Liu; Qicong Chen; Xu Liu; Mengmeng Dou; Silu Li; Jiahui Zhou; Hong Liu; Yongfu Wu; Zunnan Huang
Journal:  Biomed Res Int       Date:  2016-08-15       Impact factor: 3.411

Review 9.  Association of Choline Acetyltransferase Gene Polymorphisms (SNPs rs868750G/A, rs1880676G/A, rs2177369G/A and rs3810950G/A) with Alzheimer's Disease Risk: A Meta-Analysis.

Authors:  Hai Yuan; Qing Xia; Kang Ling; Xiaotong Wang; Xiumin Wang; Xunping Du
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

10.  Meta-analyses of 8 polymorphisms associated with the risk of the Alzheimer's disease.

Authors:  Xuting Xu; Yunliang Wang; Lingyan Wang; Qi Liao; Lan Chang; Leiting Xu; Yi Huang; Huadan Ye; Limin Xu; Cheng Chen; Xiaowei Shen; Fuqiang Zhang; Meng Ye; Qinwen Wang; Shiwei Duan
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.